Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119891643 | 11989164 | 3 | F | 201412 | 20160922 | 20160202 | 20160928 | EXP | US-ABBVIE-16K-163-1547111-00 | ABBVIE | 33.23 | YR | F | Y | 68.10000 | KG | 20160928 | CN | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119891643 | 11989164 | 1 | PS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | UNKNOWN | 125057 | 40 | MG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | QOW | ||||||
| 119891643 | 11989164 | 2 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | 0 | ||||||||||||
| 119891643 | 11989164 | 3 | C | AMBIEN | ZOLPIDEM TARTRATE | 1 | 0 | ||||||||||||
| 119891643 | 11989164 | 4 | C | PROMETHAZINE | PROMETHAZINEPROMETHAZINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 119891643 | 11989164 | 5 | C | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | 0 | ||||||||||||
| 119891643 | 11989164 | 6 | C | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | 0 | ||||||||||||
| 119891643 | 11989164 | 7 | C | PROAIR HFA | ALBUTEROL SULFATE | 1 | 0 | ||||||||||||
| 119891643 | 11989164 | 8 | C | NORCO | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | 0 | ||||||||||||
| 119891643 | 11989164 | 9 | C | OXYCODONE | OXYCODONE | 1 | 0 | ||||||||||||
| 119891643 | 11989164 | 10 | C | PREDNISONE. | PREDNISONE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119891643 | 11989164 | 1 | Crohn's disease |
| 119891643 | 11989164 | 2 | Autoimmune thyroiditis |
| 119891643 | 11989164 | 3 | Insomnia |
| 119891643 | 11989164 | 4 | Nausea |
| 119891643 | 11989164 | 5 | Nausea |
| 119891643 | 11989164 | 6 | Gastric hypomotility |
| 119891643 | 11989164 | 7 | Asthma |
| 119891643 | 11989164 | 8 | Pain |
| 119891643 | 11989164 | 9 | Breakthrough pain |
| 119891643 | 11989164 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119891643 | 11989164 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119891643 | 11989164 | Abdominal pain | |
| 119891643 | 11989164 | Coeliac artery compression syndrome | |
| 119891643 | 11989164 | Coeliac artery occlusion | |
| 119891643 | 11989164 | Coeliac artery stenosis | |
| 119891643 | 11989164 | Crohn's disease | |
| 119891643 | 11989164 | Injection site bruising | |
| 119891643 | 11989164 | Injection site erythema | |
| 119891643 | 11989164 | Injection site haemorrhage | |
| 119891643 | 11989164 | Injection site mass | |
| 119891643 | 11989164 | Lipoma | |
| 119891643 | 11989164 | Lymphadenopathy | |
| 119891643 | 11989164 | Pain | |
| 119891643 | 11989164 | Peripheral venous disease | |
| 119891643 | 11989164 | Pneumothorax | |
| 119891643 | 11989164 | Skin discolouration | |
| 119891643 | 11989164 | Skin mass | |
| 119891643 | 11989164 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119891643 | 11989164 | 1 | 20140827 | 201512 | 0 |